Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · IEX Real-Time Price · USD
1.120
-0.030 (-2.61%)
At close: Jul 19, 2024, 4:00 PM
1.110
-0.010 (-0.89%)
Pre-market: Jul 22, 2024, 7:05 AM EDT
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $16.49 million as of July 22, 2024. Its market cap has increased by 14.51% in one year.
Market Cap
16.49M
Enterprise Value
927.00K
1-Year Change
14.51%
Ranking
Category
Stock Price
$1.12
Market Cap Chart
Since February 12, 2019, Chemomab Therapeutics's market cap has decreased from $71.00M to $16.49M, a decrease of -76.78%. That is a compound annual growth rate of -23.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 15.90M | 152.38% |
| Dec 29, 2023 | 6.30M | -82.93% |
| Dec 30, 2022 | 36.90M | -53.11% |
| Dec 31, 2021 | 78.70M | 514.84% |
| Dec 31, 2020 | 12.80M | 23.08% |
| Dec 31, 2019 | 10.40M | -85.35% |
| Feb 12, 2019 | 71.00M | - |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VBI Vaccines | 17.79M |
| Aeterna Zentaris | 17.31M |
| Conduit Pharmaceuticals | 17.29M |
| Kindly MD | 17.05M |
| PharmaCyte Biotech | 17.03M |
| Aytu BioPharma | 16.84M |
| Lyra Therapeutics | 16.84M |
| Microbot Medical | 16.78M |